title: Predicting chronic GVHD outcomes: are we there yet?
abstract: In this issue of Blood, Palmer et al provide encouragement that important chronic graft-versus-host disease (GVHD) patient outcomes (such as overall survival [OS] and failure-free survival [FFS]) are predicted by clinician-assessed response, patient-reported outcomes, and 2014 National Institutes of Health (NIH)-response criteria.
authors.affiliation: CHILDREN'S NATIONAL HEALTH SYSTEM; GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES.
authors.forename: David A
authors.initials: DA
authors.lastname: Jacobsohn
mesh_terms: D005260:Female; D006086:Graft vs Host Disease / Q000401:mortality*; D019337:Hematologic Neoplasms / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D008297:Male; D063868:Patient Outcome Assessment; D057566:Self Report; D012720:Severity of Illness Index